EB-D fibronectin expression in squamous cell carcinoma of the head and neck

Oral Oncology

Volumn 41, Issue 1, 2005, Pages 82-88

  Mhawech, Paulette ^a   Dulguerov, Pavel ^b   Assaly, Mounia ^a   Ares, Carmen ^b   Allal, Abdelkarim S ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

ED B fibronectin expression; Head and neck squamous cell carcinoma; Immunohistochemistry; Prognostic value

Indexed keywords

FIBRONECTIN; GLYCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER SURVIVAL; FEMALE; HEAD AND NECK CARCINOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; FIBRONECTINS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 10644225067     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.07.003     Document Type: Article

References (28)

1. S.H. Landis, T. Murray, S. Bolden, and P.A. Wingo Cancer statistics CA Cancer J. Clin. 49 1999 8 31
2. G. Wiernik, P.R. Millard, and J.L. Haybittle The predictive value of histological classification into degrees of differentiation of squamous cell carcinoma of the larynx and hypopharynx compared with the survival of patients Histopathology 19 1991 411 417
3. J.D. Crissman, W.Y. Liu, J.L. Gluckman, and G. Cummings Prognostic value of histopathologic parameters in squamous cell carcinoma of the oropharynx Cancer 54 1984 2995 3001
4. A. DeStefani, M. Magnano, and M. Bussi Identification of clinical, biological and prognostic factors in recurring squamous cell carcinoma of the head and neck Acta Otorhinolaryngol. Ital. 17 1997 219 224
5. E. Pera, A. Moreno, and L. Galindo Prognostic factors in laryngeal cancer: amultifactorial study of 416 cases Cancer 58 1986 928 934
6. M. Liu, G. Lawson, and M. Delos Prognostic value of cell proliferation markers, tumour suppressor proteins and cell adhesion molecules in primary squamous cell carcinoma of the larynx and hypopharynx Eur. Arch. Otorhinolaryngol. 260 2003 28 34
7. B. Khademi, F.M. Shirazi, and M. Vasei The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors Cancer Lett. 184 2002 223 230
8. A.J. Khan, B.L. King, and B.D. Smith Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma Clin Cancer Res. 8 2002 540 548
9. M. Midulla, R. Verma, M. Pignatelli, M.A. Ritter, N.S. Courtenay-Luck, and A.J. George Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells Cancer Res. 60 2000 164 169
10. L. Borsi, E. Balsa, G. Allemanni, and L. Zardi Differential expression of the fibronectin isoform containing the Ed-B oncofetal domain in normal human fibroblast cell lines originating from different tissues Exp. Cell Res. 199 1992 98 105
11. H. Kosmehl, A. Berndt, and S. Strassburger Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma Br. J. Cancer 81 1999 1071 1079
12. P. Pujuguet, A. Hammann, M. Moutet, J.L. Samuel, F. Martin, and M. Martin Expression of fibronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofibroblasts Am. J. Pathol. 148 1996 579 592
13. E. Ruoslathi Fibronectin and its receptors Annu. Rev. Biochem. 57 1988 375 413
14. R.O. Hynes Molecular biology of fibronectin Annu. Rev. Cell Biol. 1 1985 67 90
15. U. Mandel, B. Gaggero, J. Reibel, T.M. Hamilton, E. Dabelsteen, and H. Clausen Oncofetal fibronectins in oral carcinomas: correlation of two different types APMIS 102 1994 695 702
16. J. Kaczmarek, P. Castellani, G. Nicolo, B. Spina, G. Allemanni, and L. Zardi Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues Int. J. Cancer 59 1994 11 16
17. B. Carnemolla, E. Balza, and A. Siri A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors J. Cell Biol. 108 1989 1139 1148
18. P. Castellani, G. Viale, and A. Dorcaratto The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis Int. J. Cancer 59 1994 612 618
19. A. Berndt, L. Borsi, X. Luo, L. Zardi, D. Katenkamp, and H. Kosmehl Evidence of ED-B+ fibronectin synthesis in human tissues by non-radioactive RNA in situ hybridization. Investigations on carcinoma (oral squamous cell and breast carcinoma), chronic inflammation (rheumatoid synovitis) and fibromatosis (Morbus Dupuytren) Histochem. Cell Biol. 109 1998 249 255
20. M.T. Birchler, D. Milisavlijevic, and M. Pfaltz Expression of the extra domain B of fibronectin, a marker of angiogenesis, in head and neck tumors Laryngoscope 113 2003 1237 12131
21. F. Nilsson, H. Kosmehl, L. Zardi, and D. Neri Targeted delivery of tissue factor to the ED-B domain of fibronectin, a marker of angiogenesis, mediates the infarction of solid tumors in mice Cancer Res. 61 2001 711 716
22. M. Birchler, F. Viti, L. Zardi, B. Speiss, and D. Neri Selective targeting and photocoagualtion of ocular angiogenesis mediated by a phage-derived human anitbody fragment Nat. Biotechnol. 17 1999 984 988
23. H. Infusa, and M. Nakamura Localization of oncofetal and normal fibin in colon cancer. Correlation with histologic grade, liver metastasis and prognosis Cancer 75 1995 2802 2808
24. A.J. Lyons, A.C. Bateman, A. Spedding, J.N. Primrose, and U. Mandel Oncofetal fibronectin and oral squamous cell carcinoma Br. J. Oral Maxillofac. Surg. 39 2001 471 477
25. M. Santimaria, G. Moscatelli, and G.L. Viale Immunoscintigraphic detection of the ED-B domain of fibronectin, a marker of angiogenesis, in patients with cancer Clin. Cancer Res. 9 2003 571 579
26. A.S. Allal, C. de Pree, P. Dulguerov, S. Bieri, D. Maire, and J.M. Kurtz Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas Int. J. Radiat. Oncol. Biol. Phys. 45 1999 41 45
27. A.S. Allal, P. Dulguerov, S. Bieri, W. Lehmann, and J.M. Kurtz A conservation approach to pharyngeal carcinoma with advanced neck disease: optimizing neck management Head Neck 21 1999 217 222
28. W. Chen, and L.A. Culp Adhesion mediated by fibronectin's alternatively spliced Edb (EDIIIB) and its neighouring type III repeats Exp. Cell Res. 223 1996 9 19